Before the official commercial launch of our technology, the Technology Access Program (TAP) will offer early access to test samples against a wide range of protein markers using Codeta's innovative technology.
Researchers investigating cytokine immune or inflammatory responses can experience our ultra-sensitive testing capabilities firsthand.
We're able to accomplish this with our simultaneous digital PCR and qPCR detection methods delivering an unprecedented eight logs of dynamic range.
Along with a novel noise canceling assay design, this technology is truly unlike anything else you have in your lab, and we're excited to show you results with your samples through this early access program.
To qualify, you must agree to a service with the 6-plex cytokine assay. You should also have plasma samples in EDTA that you can send to our lab.
Complete the form below. We will contact you and discuss next steps. We will review sample type, logistics and turn-around time.
Send us your samples and we take care of the rest: sample prep, run the assay and deliver results.
Experience the precision and sensitivity of our assays, especially valuable for studying immune cytokines and inflammatory responses
Receive detailed and accurate data on your samples, which can significantly advance your research
Watch our CEO introduce the Codetta technology platform and the Technology Access Program.
Learn how you can experience the Codetta Bio Platform by joining the Technology Access Program.
